A detailed history of Westover Capital Advisors, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 5,042 shares of MEDP stock, worth $2.05 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
5,042
Previous 4,966 1.53%
Holding current value
$2.05 Million
Previous $1.52 Million 33.84%
% of portfolio
0.6%
Previous 0.5%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$284.87 - $413.31 $21,650 - $31,411
76 Added 1.53%
5,042 $2.04 Million
Q4 2023

Feb 06, 2024

BUY
$227.52 - $312.68 $165,179 - $227,005
726 Added 17.12%
4,966 $1.52 Million
Q3 2023

Nov 13, 2023

SELL
$233.98 - $281.67 $59,664 - $71,825
-255 Reduced 5.67%
4,240 $1.03 Million
Q2 2023

Aug 11, 2023

BUY
$187.26 - $240.17 $234,075 - $300,212
1,250 Added 38.52%
4,495 $1.08 Million
Q1 2023

May 22, 2023

SELL
$174.31 - $239.52 $697 - $958
-4 Reduced 0.12%
3,245 $610,000
Q4 2022

May 18, 2023

SELL
$153.06 - $226.57 $591,883 - $876,146
-3,867 Reduced 54.34%
3,249 $690,000
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $19,447 - $24,453
-134 Reduced 1.85%
7,116 $1.12 Million
Q2 2022

Aug 12, 2022

SELL
$130.2 - $168.03 $33,591 - $43,351
-258 Reduced 3.44%
7,250 $1.09 Million
Q1 2022

May 13, 2022

SELL
$138.87 - $214.31 $95,264 - $147,016
-686 Reduced 8.37%
7,508 $1.23 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $179,085 - $223,342
-980 Reduced 10.68%
8,194 $1.78 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $3,573 - $4,162
-21 Reduced 0.23%
9,174 $1.74 Million
Q2 2021

Aug 10, 2021

SELL
$158.62 - $194.3 $99,454 - $121,826
-627 Reduced 6.38%
9,195 $1.62 Million
Q1 2021

May 18, 2021

SELL
$132.02 - $168.26 $106,012 - $135,112
-803 Reduced 7.56%
9,822 $1.61 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $22,969 - $31,329
-210 Reduced 1.94%
10,625 $1.48 Million
Q3 2020

Nov 19, 2020

SELL
$92.95 - $130.61 $236,836 - $332,794
-2,548 Reduced 19.04%
10,835 $1.21 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $196,342 - $275,941
-2,884 Reduced 17.73%
13,383 $1.25 Million
Q1 2020

May 18, 2020

BUY
$61.71 - $101.95 $17,587 - $29,055
285 Added 1.78%
16,267 $1.19 Million
Q4 2019

Feb 11, 2020

SELL
$70.08 - $84.64 $31,676 - $38,257
-452 Reduced 2.75%
15,982 $1.34 Million
Q3 2019

Nov 12, 2019

SELL
$62.38 - $85.89 $122,202 - $168,258
-1,959 Reduced 10.65%
16,434 $1.38 Million
Q2 2019

Aug 13, 2019

SELL
$53.64 - $65.42 $50,314 - $61,363
-938 Reduced 4.85%
18,393 $1.2 Million
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $64,391 - $92,036
1,304 Added 7.23%
19,331 $1.14 Million
Q4 2018

Feb 14, 2019

BUY
$46.97 - $63.98 $846,728 - $1.15 Million
18,027 New
18,027 $954,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Westover Capital Advisors, LLC Portfolio

Follow Westover Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.